VanEck Associates’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-696	Closed	-$40K	–	1279
2021 Q1	$40K	Buy	696 +10	+1%	+$575	﹤0.01%	1100
2020 Q4	$47K	Buy	686 +157	+30%	+$10.8K	﹤0.01%	968
2020 Q3	$134K	Buy	529 +11	+2%	+$2.79K	﹤0.01%	855
2020 Q2	$87K	Buy	+518	New	+$87K	﹤0.01%	868